Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
629 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01582295 | XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease | completed | Phase 1 | 4 | Massachusetts General HospitalOTHER | 1 | May 25, 2017 | clinicaltrials |
| NCT02204631 | 2 Phase Use Of Educational Materials In Head And Neck Cancer Center | completed | N/A | 60 | Massachusetts General HospitalOTHER | 1 | May 25, 2017 | clinicaltrials |
| NCT00356031 |
| Bevacizumab and Radiation Therapy for Sarcomas |
| completed |
| Phase 2 |
| 20 |
| Massachusetts General HospitalOTHER |
| 1 |
| May 19, 2017 |
| clinicaltrials |
| NCT01583543 | Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma | completed | Phase 2 | 12 | Massachusetts General HospitalOTHER | 1 | May 19, 2017 | clinicaltrials |
| NCT00842257 | Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer | completed | Phase 2 | 20 | Massachusetts General HospitalOTHER | 1 | May 16, 2017 | clinicaltrials |
| NCT02243007 | Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer | terminated | Phase 2 | 7 | Massachusetts General HospitalOTHER | 1 | May 16, 2017 | clinicaltrials |
| NCT03106337 | Diagnostic Accuracy of Shear-Wave Elastography for the Preoperative Risk Stratification of Follicular Lesions of the Thyroid | completed | N/A | 35 | Massachusetts General HospitalOTHER | 1 | May 16, 2017 | clinicaltrials |
| NCT00366457 | Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer | completed | Phase 2 | 32 | Massachusetts General HospitalOTHER | 1 | May 15, 2017 | clinicaltrials |
| NCT01215032 | Metformin in Castration-Resistant Prostate Cancer | terminated | Phase 2 | 21 | Massachusetts General HospitalOTHER | 1 | May 15, 2017 | clinicaltrials |
| NCT00307736 | Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer | completed | Phase 1 / Phase 2 | 32 | Massachusetts General HospitalOTHER | 1 | May 10, 2017 | clinicaltrials |
| NCT00948688 | Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas | terminated | Phase 1 / Phase 2 | 10 | Massachusetts General HospitalOTHER | 1 | May 10, 2017 | clinicaltrials |
| NCT01282476 | Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma | terminated | Phase 2 | 18 | Massachusetts General HospitalOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT00157573 | GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer | completed | Phase 2 | 72 | Massachusetts General HospitalOTHER | 0 | May 8, 2017 | clinicaltrials |
| NCT01543607 | Endoscopic Therapy of Malignant Bile Duct Strictures | terminated | N/A | 1 | Massachusetts General HospitalOTHER | 1 | Apr 24, 2017 | clinicaltrials |
| NCT01849588 | HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC) | terminated | Phase 4 | 3 | Massachusetts General HospitalOTHER | 1 | Apr 19, 2017 | clinicaltrials |
| NCT02069769 | Ensuring Communication in Hospice by Oncology Study (ECHO) | completed | N/A | 30 | Massachusetts General HospitalOTHER | 1 | Apr 18, 2017 | clinicaltrials |
| NCT01825213 | Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT | completed | — | 10 | Massachusetts General HospitalOTHER | 1 | Apr 17, 2017 | clinicaltrials |
| NCT01173679 | Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory CLL and SLL | terminated | Phase 2 | 10 | Massachusetts General HospitalOTHER | 1 | Apr 14, 2017 | clinicaltrials |
| NCT00392665 | Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck | terminated | Phase 2 | 36 | Massachusetts General HospitalOTHER | 1 | Apr 13, 2017 | clinicaltrials |
| NCT01754376 | Combined BRAF-Targeted Therapy & Immunotherapy for Melanoma | terminated | Phase 2 | 6 | Massachusetts General HospitalOTHER | 1 | Apr 12, 2017 | clinicaltrials |
| NCT00977275 | Treatment of T1N0 Invasive Breast Carcinoma by Local Excision Implant | completed | Phase 1 / Phase 2 | 45 | Massachusetts General HospitalOTHER | 1 | Apr 11, 2017 | clinicaltrials |
| NCT00096291 | Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast Cancer | completed | Phase 2 | 62 | Massachusetts General HospitalOTHER | 1 | Apr 10, 2017 | clinicaltrials |
| NCT00642759 | Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 36 | Massachusetts General HospitalOTHER | 1 | Apr 7, 2017 | clinicaltrials |
| NCT01611675 | Leflunomide+Vemurafenib in V600 Mutant Met. Melanoma | terminated | Phase 1 | 3 | Massachusetts General HospitalOTHER | 1 | Apr 6, 2017 | clinicaltrials |
| NCT02435628 | Relationship Between Psychosocial Factors, Health Literacy, Quality of Life and Satisfaction With Medical Visits in Adults With NF | completed | — | 86 | Massachusetts General HospitalOTHER | 1 | Apr 4, 2017 | clinicaltrials |
| NCT00973752 | Treatment of Older Adults With Acute Lymphoblastic Leukemia | completed | Phase 2 | 30 | Massachusetts General HospitalOTHER | 1 | Mar 30, 2017 | clinicaltrials |
| NCT00549822 | Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer | terminated | Phase 2 | 3 | Massachusetts General HospitalOTHER | 1 | Mar 22, 2017 | clinicaltrials |
| NCT01398501 | Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant | completed | Phase 1 | 22 | Massachusetts General HospitalOTHER | 1 | Mar 22, 2017 | clinicaltrials |
| NCT02724904 | Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma | withdrawn | Phase 1 / Phase 2 | 0 | Massachusetts General HospitalOTHER | 1 | Mar 22, 2017 | clinicaltrials |
| NCT01534897 | Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436 | completed | N/A | 10 | Massachusetts General HospitalOTHER | 1 | Mar 15, 2017 | clinicaltrials |
| NCT00577642 | Bone Marker Assessment of Multiple Myeloma Patients Treated With Aminobisphosphonates | completed | Phase 2 | 29 | Massachusetts General HospitalOTHER | 1 | Mar 10, 2017 | clinicaltrials |
| NCT01181271 | Tandem Auto-Allo Transplant for Lymphoma | completed | Phase 2 | 42 | Massachusetts General HospitalOTHER | 1 | Mar 9, 2017 | clinicaltrials |
| NCT00681473 | Late Effects of Proton Radiation Therapy in Patients With Low-Grade Glioma | completed | N/A | 20 | Massachusetts General HospitalOTHER | 1 | Mar 7, 2017 | clinicaltrials |
| NCT00513383 | Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck | completed | Phase 1 | 34 | Massachusetts General HospitalOTHER | 1 | Mar 1, 2017 | clinicaltrials |
| NCT00361244 | SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer | terminated | Phase 1 / Phase 2 | 6 | Massachusetts General HospitalOTHER | 1 | Feb 17, 2017 | clinicaltrials |
| NCT01779843 | Alisertib for Acute Myeloid Leukemia | completed | Phase 1 | 22 | Massachusetts General HospitalOTHER | 1 | Feb 17, 2017 | clinicaltrials |
| NCT01843179 | Sulindac for Patients With AML | withdrawn | Phase 2 | 0 | Massachusetts General HospitalOTHER | 1 | Feb 17, 2017 | clinicaltrials |
| NCT00361231 | Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer | completed | Phase 2 | 35 | Massachusetts General HospitalOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00516165 | RAD001 in Advanced Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 28 | Massachusetts General HospitalOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00592345 | High-Dose Proton/Photon RT + Surgery of Sarcomas of the Thoracic, Lumbar Spine/Sacrum | completed | Phase 1 / Phase 2 | 50 | Massachusetts General HospitalOTHER | 1 | Feb 3, 2017 | clinicaltrials |
| NCT00713037 | Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas | completed | N/A | 20 | Massachusetts General HospitalOTHER | 1 | Feb 3, 2017 | clinicaltrials |
| NCT01954745 | Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma | completed | Phase 2 | 19 | Massachusetts General HospitalOTHER | 1 | Feb 3, 2017 | clinicaltrials |
| NCT01401894 | Perception Prognosis, Goals of Treatment, and Communication | completed | — | 50 | Massachusetts General HospitalOTHER | 1 | Jan 31, 2017 | clinicaltrials |
| NCT01026844 | Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC) | terminated | Phase 1 | 27 | Massachusetts General HospitalOTHER | 1 | Jan 30, 2017 | clinicaltrials |
| NCT00465023 | Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases | completed | N/A | 16 | Massachusetts General HospitalOTHER | 0 | Jan 20, 2017 | clinicaltrials |
| NCT00445653 | Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding | completed | — | 170 | Massachusetts General HospitalOTHER | 1 | Jan 18, 2017 | clinicaltrials |
| NCT00865644 | Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1 | completed | Phase 1 | 11 | Massachusetts General HospitalOTHER | 1 | Jan 10, 2017 | clinicaltrials |
| NCT02035345 | Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment | terminated | Phase 4 | 15 | Massachusetts General HospitalOTHER | 1 | Dec 8, 2016 | clinicaltrials |
| NCT01347788 | Cabozantinib (XL184) in Men With Castrate-Resistant Prostate Cancer | completed | Phase 1 | 34 | Massachusetts General HospitalOTHER | 1 | Nov 28, 2016 | clinicaltrials |
| NCT00706485 | Intra-Operative Dural Brachytherapy With Yttrium-90 Plaque Applicators | terminated | N/A | 5 | Massachusetts General HospitalOTHER | 1 | Oct 19, 2016 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials